Hawaii Senate Votes Unanimously to Allow Medical Cannabis for Lupus, Epilepsy, Multiple Sclerosis, Arthritis and Autism
A Hawaii measure that would expand the list of qualifying medical cannabis conditions has been passed by the state’s full Senate.
Senate Bill 174 was passed today with a unanimous 25 to 0 vote. It now goes to the House of Representatives, where its passage will send it to Governor David Ige for consideration.
If passed into law, the proposal would allow those with lupus, epilepsy, multiple sclerosis, arthritis and autism to become registered medical cannabis patients, allowing them to possess, purchase (from a licensed dispensary) and use cannabis and cannabis products for medical use.
The full text of the 1-page measure can be found by clicking here.
Below is a list of the conditions that currently qualify someone to become a legal medical cannabis patient in Hawaii:
Cancer, glaucoma, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, or the treatment of these conditions;
(2) A chronic or debilitating disease or medical condition or its treatment that produces one or more of the following:
(A) Cachexia or wasting syndrome;
(B) Severe pain;
(C) Severe nausea;
(D) Seizures, including those characteristic of epilepsy;
(E) Severe and persistent muscle spasms, including those characteristic of multiple sclerosis or Crohn’s disease; or
(F) Post-traumatic stress disorder